Clinical Trials Logo

Episodic Cluster Headache clinical trials

View clinical trials related to Episodic Cluster Headache.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT02945046 Terminated - Clinical trials for Episodic Cluster Headache

A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)

Start date: January 19, 2017
Phase: Phase 3
Study type: Interventional

This is a 13-week, multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study to compare the efficacy and safety of 2 dose regimens of TEV-48125 (Fremanezumab) versus placebo in adult participants for the prevention of ECH.

NCT ID: NCT02209155 Terminated - Clinical trials for Episodic Cluster Headache

R-Verapamil for the Prophylaxis of Episodic Cluster Headache

Start date: November 2013
Phase: Phase 2
Study type: Interventional

This is a double-blinded, randomized, parallel, placebo-controlled phase 2 study to evaluate the safety and efficacy of R-verapamil in the prophylaxis of episodic cluster headache.